Enrofloxacin is a fluoroquinolone antibiotic sold by the Bayer Corporation. It is a bactericidal agent. The bactericidal activity of enrofloxacin is concentration-dependent, with susceptible bacteria cell death occurring within 20–30 minutes of exposure. Enrofloxacin has demonstrated a significant post-antibiotic effect for both Gram-negative and Gram-positive bacteria and is active in both stationary and growth phases of bacterial replication.
Properties:
Appearance & Physical State: Pale Yellow Crystals
Density: 1.385g/cm3
Melting Point: 221-226ºC
Boiling Point: 560.5ºC at 760mmHg
Flash Point: 292.8ºC
Antibiotics chemical Related Products:
Doripenem Hydrate; Meropenem; Linezolid; Cefoselis Sulfate; Tebipenem; Tebipenem pivoxil; Amphotericin B; Aztreonam; Cefaclor; Tobramycin; Roxithromycin; Nadifloxacin; Gamithromycin; Orbifloxacin; Polymyxin B Sulfate; Kanamycin; Tildipirosin; Ertapenem Sodium; Faropenem sodium; Ceftizoxime